STOCK TITAN

[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

GE HealthCare Technologies insider transaction: Kenneth R. Stacherski, Chief Enterprise Operating Officer, reported two disposals of GEHC common stock on 09/01/2025. The filings show 458 shares and 434 shares were disposed of at a price of $73.73 per share, resulting in 41,430 and 40,996 shares beneficially owned after each reported transaction.

The form states these disposals represent withholding of shares to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The Form 4 was signed by the company’s General Counsel as attorney-in-fact on 09/03/2025.

Operazione interna di GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, ha dichiarato due cessioni di azioni ordinarie GEHC in data 01/09/2025. I documenti indicano che sono state cedute 458 azioni e 434 azioni al prezzo di $73,73 per azione, con un conseguente possesso effettivo di 41.430 e 40.996 azioni dopo ciascuna delle operazioni riportate.

Il modulo specifica che queste cessioni rappresentano la ritenuta di azioni per soddisfare gli obblighi di pagamento delle imposte connessi al maturare di restricted stock units. Il Modulo 4 è stato firmato dall’Avvocato Generale della società in qualità di procuratore il 03/09/2025.

Transacción de un insider de GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, informó dos disposiciones de acciones ordinarias de GEHC el 01/09/2025. Los registros muestran que se dispusieron 458 acciones y 434 acciones a un precio de $73.73 por acción, resultando en 41.430 y 40.996 acciones en propiedad beneficiosa tras cada transacción reportada.

El formulario indica que estas disposiciones representan la retención de acciones para cumplir con las obligaciones de retención de impuestos en relación con la consolidación de restricted stock units. El Formulario 4 fue firmado por el Asesor General de la compañía como apoderado el 03/09/2025.

GE HealthCare Technologies 내부자 거래: 최고 엔터프라이즈 운영책임자(Chief Enterprise Operating Officer) Kenneth R. Stacherski는 2025-09-01에 GEHC 보통주 2건의 처분을 신고했습니다. 제출 서류에 따르면 각각 458주와 434주가 주당 $73.73에 처분되었으며, 각 신고 거래 후 보유 유익지분은 각각 41,430주와 40,996주로 나타났습니다.

해당 양식은 이 처분들이 제한주식단위(restricted stock units)의 취득과 관련된 세금 원천징수 의무를 충족하기 위해 주식을 원천징수한 것임을 명시하고 있습니다. Form 4는 회사 법무담당이 대리인으로서 2025-09-03에 서명했습니다.

Transaction d'initié de GE HealthCare Technologies : Kenneth R. Stacherski, Chief Enterprise Operating Officer, a déclaré deux cessions d'actions ordinaires GEHC le 01/09/2025. Les documents indiquent que 458 actions et 434 actions ont été cédées au prix de 73,73 $ par action, entraînant une propriété bénéficiaire de 41 430 et 40 996 actions après chacune des transactions déclarées.

Le formulaire précise que ces cessions correspondent à la retenue d'actions afin de satisfaire les obligations de retenue fiscale liées à l'acquisition de restricted stock units. Le formulaire 4 a été signé par le General Counsel de la société en tant que mandataire le 03/09/2025.

Insider-Transaktion von GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, meldete am 01.09.2025 zwei Veräußerungen von GEHC-Stammaktien. Aus den Unterlagen geht hervor, dass 458 und 434 Aktien zu je $73,73 veräußert wurden, wodurch sich nach den jeweiligen gemeldeten Transaktionen ein wirtschaftlicher Besitz von 41.430 bzw. 40.996 Aktien ergibt.

Das Formular gibt an, dass diese Veräußerungen die Einbehaltung von Aktien zur Erfüllung von Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units darstellen. Das Formular 4 wurde am 03.09.2025 vom General Counsel des Unternehmens als Bevollmächtigtem unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR Routine insider tax-withholding sales tied to RSU vesting, not a consultative market signal.

The reported transactions are labeled as disposals due to withholding to satisfy tax obligations on vesting restricted stock units. Transaction codes (F) indicate disposition by other means, consistent with share-withholding for taxes rather than open-market sales to raise cash. The sizes—458 and 434 shares at $73.73—are small relative to total holdings of ~41,000 shares, implying limited direct impact on float or valuation.

TL;DR Administrative compliance filing showing standard RSU withholding; no governance red flags apparent.

The Form 4 discloses routine compliance with Section 16 reporting requirements. The use of an attorney-in-fact signature and explicit explanation that shares were withheld for tax withholding are normal. There is no indication of unusual timing, related-party transactions, or departures from typical equity compensation administration in the filing.

Operazione interna di GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, ha dichiarato due cessioni di azioni ordinarie GEHC in data 01/09/2025. I documenti indicano che sono state cedute 458 azioni e 434 azioni al prezzo di $73,73 per azione, con un conseguente possesso effettivo di 41.430 e 40.996 azioni dopo ciascuna delle operazioni riportate.

Il modulo specifica che queste cessioni rappresentano la ritenuta di azioni per soddisfare gli obblighi di pagamento delle imposte connessi al maturare di restricted stock units. Il Modulo 4 è stato firmato dall’Avvocato Generale della società in qualità di procuratore il 03/09/2025.

Transacción de un insider de GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, informó dos disposiciones de acciones ordinarias de GEHC el 01/09/2025. Los registros muestran que se dispusieron 458 acciones y 434 acciones a un precio de $73.73 por acción, resultando en 41.430 y 40.996 acciones en propiedad beneficiosa tras cada transacción reportada.

El formulario indica que estas disposiciones representan la retención de acciones para cumplir con las obligaciones de retención de impuestos en relación con la consolidación de restricted stock units. El Formulario 4 fue firmado por el Asesor General de la compañía como apoderado el 03/09/2025.

GE HealthCare Technologies 내부자 거래: 최고 엔터프라이즈 운영책임자(Chief Enterprise Operating Officer) Kenneth R. Stacherski는 2025-09-01에 GEHC 보통주 2건의 처분을 신고했습니다. 제출 서류에 따르면 각각 458주와 434주가 주당 $73.73에 처분되었으며, 각 신고 거래 후 보유 유익지분은 각각 41,430주와 40,996주로 나타났습니다.

해당 양식은 이 처분들이 제한주식단위(restricted stock units)의 취득과 관련된 세금 원천징수 의무를 충족하기 위해 주식을 원천징수한 것임을 명시하고 있습니다. Form 4는 회사 법무담당이 대리인으로서 2025-09-03에 서명했습니다.

Transaction d'initié de GE HealthCare Technologies : Kenneth R. Stacherski, Chief Enterprise Operating Officer, a déclaré deux cessions d'actions ordinaires GEHC le 01/09/2025. Les documents indiquent que 458 actions et 434 actions ont été cédées au prix de 73,73 $ par action, entraînant une propriété bénéficiaire de 41 430 et 40 996 actions après chacune des transactions déclarées.

Le formulaire précise que ces cessions correspondent à la retenue d'actions afin de satisfaire les obligations de retenue fiscale liées à l'acquisition de restricted stock units. Le formulaire 4 a été signé par le General Counsel de la société en tant que mandataire le 03/09/2025.

Insider-Transaktion von GE HealthCare Technologies: Kenneth R. Stacherski, Chief Enterprise Operating Officer, meldete am 01.09.2025 zwei Veräußerungen von GEHC-Stammaktien. Aus den Unterlagen geht hervor, dass 458 und 434 Aktien zu je $73,73 veräußert wurden, wodurch sich nach den jeweiligen gemeldeten Transaktionen ein wirtschaftlicher Besitz von 41.430 bzw. 40.996 Aktien ergibt.

Das Formular gibt an, dass diese Veräußerungen die Einbehaltung von Aktien zur Erfüllung von Steuerabzugsverpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units darstellen. Das Formular 4 wurde am 03.09.2025 vom General Counsel des Unternehmens als Bevollmächtigtem unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stacherski Kenneth R.

(Last) (First) (Middle)
500 W. MONROE STREET

(Street)
CHICAGO IL 60661

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Enterprise Oper. Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 09/01/2025 F 458(1) D $73.73 41,430 D
Common Stock, par value $0.01 per share 09/01/2025 F 434(1) D $73.73 40,996 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider sold shares of GE HealthCare Technologies (GEHC)?

Kenneth R. Stacherski, Chief Enterprise Operating Officer, reported the disposals.

How many GEHC shares were disposed of and at what price?

Two disposals: 458 shares and 434 shares at a reported price of $73.73 per share on 09/01/2025.

Why were the GEHC shares disposed of according to the Form 4?

The filing states the shares were withheld to satisfy tax withholding obligations in connection with vesting of restricted stock units.

How many GEHC shares did the reporting person beneficially own after the transactions?

The Form shows beneficial ownership of 41,430 and 40,996 shares following the reported transactions.

When was the Form 4 signed and by whom?

The Form 4 was executed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact on 09/03/2025.
Ge Healthcare Technologies Inc

NASDAQ:GEHC

GEHC Rankings

GEHC Latest News

GEHC Latest SEC Filings

GEHC Stock Data

33.84B
455.24M
0.28%
87.11%
1.98%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
CHICAGO